These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37587270)

  • 21. Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugs.
    Hata T; Nakamura K; Yonemori K; Noguchi E; Watanabe M; Sohn J; Lu YS; Yap YS; Tamura K; Fujiwara Y
    Clin Transl Sci; 2021 May; 14(3):1015-1025. PubMed ID: 33382914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of efficacy outcomes of anticancer drugs between Japanese patients and the overall population.
    Tamai T; Kaneko M; Narukawa M
    Int J Clin Oncol; 2021 Feb; 26(2):296-304. PubMed ID: 33057897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth in chikungunya virus-related research in ASEAN and South Asian countries from 1967 to 2022 following disease emergence: a bibliometric and graphical analysis.
    Sofyantoro F; Frediansyah A; Priyono DS; Putri WA; Septriani NI; Wijayanti N; Ramadaningrum WA; Turkistani SA; Garout M; Aljeldah M; Al Shammari BR; Alwashmi ASS; Alfaraj AH; Alawfi A; Alshengeti A; Aljohani MH; Aldossary S; Rabaan AA
    Global Health; 2023 Feb; 19(1):9. PubMed ID: 36747262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Similarities and differences in diagnosis and treatment of gastrointestinal stromal tumors between China, Japan and Korea: from expert consensus to cooperation prospect].
    Cao H; Wang M
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):812-819. PubMed ID: 31550818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Next stage of collaboration in East Asia gastric cancer treatment.
    Xie T; Zhang Z; Peng Z; Shen L
    Chin Clin Oncol; 2023 Aug; 12(4):39. PubMed ID: 37475646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Investigation in the Comparability of the Exposure and Recommended Dose of Selected Pfizer Drugs in East Asian Countries: Is Mutual Usage of Clinical Data Among East Asian Countries Feasible?
    Wang DD; Yu Y; Fukuhara K; Liu Y; Park SY; Parivar K
    J Clin Pharmacol; 2024 May; 64(5):609-618. PubMed ID: 38105399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Revolution without ideology: demographic transition in East Asia.
    Anderson TD
    Philipp Geogr J; 1980; 24(1):33-44. PubMed ID: 12338953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Consistency of Treatment Response Across Regions-the LEADER Trial in Relation to the ICH E17 Guideline.
    Nielsen HK; DeChiaro S; Goldman B
    Front Med (Lausanne); 2021; 8():662775. PubMed ID: 34136501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scientific publications on orthopedic surgery from three major East Asian countries (2012-2021).
    Chen WY; Xiao X; Pan C; Huang FH; Xu HY; Wei QJ; Jiang H
    World J Orthop; 2023 Aug; 14(8):641-650. PubMed ID: 37662667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical trials for drug registrations in Asian-Pacific countries: proposal for a new paradigm from a statistical perspective.
    Shih WJ
    Control Clin Trials; 2001 Aug; 22(4):357-66. PubMed ID: 11514037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence of frequent introductions of Japanese encephalitis virus from south-east Asia and continental east Asia to Japan.
    Nabeshima T; Loan HTK; Inoue S; Sumiyoshi M; Haruta Y; Nga PT; Huoung VTQ; Del Carmen Parquet M; Hasebe F; Morita K
    J Gen Virol; 2009 Apr; 90(Pt 4):827-832. PubMed ID: 19264633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors Affecting Drug-Development Strategies in Asian Global Clinical Trials for Drug Approval in Japan.
    Asano K; Uyama Y; Tohkin M
    Clin Transl Sci; 2018 Mar; 11(2):182-188. PubMed ID: 29139198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ELSI practices in genomic research in East Asia: implications for research collaboration and public participation.
    Yoshizawa G; Ho CW; Zhu W; Hu C; Syukriani Y; Lee I; Kim H; Tsai DF; Minari J; Kato K
    Genome Med; 2014; 6(5):39. PubMed ID: 24944586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Drug Characteristics for Implementing Multiregional Clinical Trials Including Japan.
    Rokuda M; Matsumaru N; Tsukamoto K
    Clin Ther; 2018 Feb; 40(2):284-295. PubMed ID: 29361305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bayesian multiregional clinical trials using model averaging.
    Bean NW; Ibrahim JG; Psioda MA
    Biostatistics; 2023 Apr; 24(2):262-276. PubMed ID: 34296263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploratory Analysis of Drug Lag in New Oncology Drugs Between Japan and the US.
    Maki A; Narukawa M
    Ther Innov Regul Sci; 2023 Jul; 57(4):671-677. PubMed ID: 36966205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bayesian joint models for multi-regional clinical trials.
    Bean NW; Ibrahim JG; Psioda MA
    Biostatistics; 2024 Jul; 25(3):852-866. PubMed ID: 37669215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid Globalization of Medical Device Clinical Development Programs in Japan　- The Case of Drug-Eluting Stents.
    Murakami M; Suzuki Y; Tominaga T
    Circ J; 2018 Feb; 82(3):636-643. PubMed ID: 28883226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involving South Asian patients in clinical trials.
    Hussain-Gambles M; Leese B; Atkin K; Brown J; Mason S; Tovey P
    Health Technol Assess; 2004 Oct; 8(42):iii, 1-109. PubMed ID: 15488164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Practical issues and lessons learned from multi-regional clinical trials via case examples: a Japanese perspective.
    Ando Y; Hamasaki T
    Pharm Stat; 2010; 9(3):190-200. PubMed ID: 20737442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.